Lv11
30 积分 2024-03-02 加入
Burden of major cancers in China attributable to modifiable risk factors: Predictions from 2012 to 2035
8天前
已完结
Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy
2个月前
已完结
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
5个月前
已完结
皖公网安备34019202002308
